- 作者：F. Moissenet ; Dr ; florent.moissenet@rehazenter.lu" class="auth_mail" title="E-mail the corresponding author ; F. Chantraine ; Dr ; C. Schreiber ; E. Kolanowski ; Dr
- 关键词：Functional electrical stimulation ; Drop foot ; Gait ; Stroke
- 刊名：Annals of Physical and Rehabilitation Medicine
- 出版年：2015
- 出版时间：September 2015
- 年：2015
- 卷：58
- 期：supp_S1
- 页码：e157-e158
- 全文大小：247 K
Material and method
Twelve patients (4 women, 8 men, 45.45 ± 12.88 years, 171.92 ± 8.07 cm, 81.14 ± 20.30 kg) were selected and implanted with a Actigait stimulator (Neurodan, Denmark, OttoBock Group) in the CHL hospital of Luxembourg. A 12-month follow-up was proposed in CNRFR, Rehazenter to these patients composed of 4 assessments (1 month before implantation and 3, 6 and 12 months after implantation). At each assessment, a 10-m walk test, a 6-min walk test, a four-square step test and a clinical gait analysis were performed. A t-test was used to evaluate the improvement of each parameter with confidence level of 95%.
Results
Most of the followed parameters, such as gait symmetry, foot/ankle kinematics and balance, are significantly improved after implantation. However, the 10-m walk test does not show any significant gait velocity improvement. Similarly, no significant effect appears on the compensations developed during gait. Even if the stimulator mainly has an orthotic effect, a therapeutic effect is shown for this patient group on the foot prepositioning in dorsiflexion at foot strike.
Discussion
Unlike recent results reported in the literature [1], gait velocity does not seem to be impacted by the use of the stimulator during gait. However, the global quality of gait is improved, with a better gait symmetry, a reduced risk of falling and a better balance. The use of an implantable peroneal nerve stimulator in the drop-foot treatment of stroke survivors is encouraging. Since it does not produce pain and is easy to use, such a device is becoming more and more an essential tool in the treatment of gait disorders.